Sort
10,829 grants matching “car t”
The role of CEACAM1 in oncogenic B-cell receptor signaling and immunotherapy in mantle cell lymphoma
$393,530Vu Nguyen Ngo · Beckman Research Institute/City Of Hope · R01 · FY2023 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$393,420Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2009 · CA
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
$393,420Renier Joseph Brentjens · Sloan-Kettering Inst Can Research · R01 · FY2010 · CA
Leveraging cancer-evolved resistance mechanisms to enhance EZH2 activity in adoptive T cells
$393,401Alan Jackson Tackett · Univ Of Arkansas For Med Scis · R21 · FY2024 · CA
TOPIC 429 - CCAL: FULLY AUTOMATED SYSTEM FOR CELL THERAPY PROCESSING (SBIR)
$393,312Emilio Barbera-Guillem · Celartia, Inc · N43 · FY2021 · CA
Safety signal learning in Rhesus monkeys following early life stressChallenge Ar
$392,964Michael Davis · Emory University · RC1 · FY2009 · MH
CAR-based approaches for the treatment of Alzheimer's Disease
$392,916Gary E. Grajales-Reyes · Washington University · DP5 · FY2022 · OD
Bounds Approaches to Empirical Market Design
$392,892Brad Larsen · National Bureau Of Economic Research Inc · · FY2015 · SBE
MSPA-MCS: Data-Driven Parallelization of Time in Molecular Dynamics Simulations
$392,890Ashok Srinivasan · Florida State University · · FY2006 · MPS
Image-guided irreversible electroporation directed CAR T-cell delivery to solid tumors
$392,764Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
Immune Activating CAR-Modified Antigen Presenting Cells
$392,709Carl Deselm · Washington University · DP5 · FY2019 · OD
Novel noncanonical actions of CAR in human Liver
$392,612Hongbing Wang · University Of Maryland Baltimore · R01 · FY2023 · CA
Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AML
$392,480Jeffrey S Miller · University Of Minnesota · P01 · FY2025 · CA
Clinical Protocol and Data Management
$392,176Elizabeth Anderson · Stanford University · P30 · FY2024 · CA
Clinical Protocol and Data Management
$392,176Elizabeth Anderson · Stanford University · P30 · FY2023 · CA
Clinical Protocol and Data Management
$392,176Elizabeth Anderson · Stanford University · P30 · FY2022 · CA
CAREER: Quantitative Evaluation Of Attention Models Of Visual Search
$392,164Miguel Eckstein · University Of California-Santa Barbara · · FY2002 · SBE
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$391,766Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA
Color Constancy
$391,535David H Brainard · University Of Pennsylvania · R01 · FY2018 · EY
Color Constancy
$391,535David H Brainard · University Of Pennsylvania · R01 · FY2017 · EY
Color Constancy
$391,535David H Brainard · University Of Pennsylvania · R01 · FY2016 · EY
Project 1: Evaluation of Second Generation Lassa Fever Immunoassays as Point-of-Care Diagnostics and Surveillance Tools for Lassa Fever.
$391,469Jeffrey G Shaffer · Tulane University Of Louisiana · U19 · FY2019 · AI
Core A: Administrative and Clinical Translational Core
$391,372Carl H. June · University Of Pennsylvania · P01 · FY2025 · CA
DEVELOPMENT & EVALUATION OF PRACTICABLE APPROACHES FOR GENERATION OF CYTOTOXIC &
$391,307Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
Prevention of adenovirus pathogenesis through downregulation of the apical adenovirus receptor
$391,040Abimbola Olayinka Kolawole · Wright State University · R01 · FY2020 · AI